Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-11 Choline PET in High-Risk Prostate Cancer
NCT02852122Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jan 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of choline C 11 in prostate cancer (PCa), sponsored by Chang Gung Memorial Hospital. Primary endpoint: The Role of C-11 Choline PET in Patients with Prostate Cancer at 2 years. Started Jan 2015; status: completed.
02
Drugs
choline C 11
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02852122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02852122.